Phillip E. Lee - Dec 16, 2022 Form 4 Insider Report for Vaxart, Inc. (VXRT)

Role
Chief Financial Officer
Signature
/s/ Edward Berg, Attorney-in-Fact for W. Mark Watson
Stock symbol
VXRT
Transactions as of
Dec 16, 2022
Transactions value $
$0
Form type
4
Date filed
12/30/2022, 07:21 PM
Previous filing
Dec 30, 2022
Next filing
May 11, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VXRT Common Stock Award $0 +68.8K $0.00 68.8K Dec 16, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VXRT Stock Option (Right to Buy) Award $0 +413K $0.00 413K Dec 16, 2022 Common Stock 413K $1.06 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of shares upon vesting of restricted stock units ("RSUs"). The RSUs vest as to 25% of the shares underlying the award on each anniversary of December 15, 2022 (the "Start Date"), so that the RSUs would be fully vested on the fourth anniversary of the Start Date.
F2 The shares subject to this stock option shall vest as to 25% of the shares underlying the grant on December 15,2023, the first anniversary of the Start Date, and thereafter in 36 equal monthly installments such that the stock option shall be fully vested on December 16, 2026.